Cargando…
Primary tumor and metastasis—sectioning the different steps of the metastatic cascade
Patients with lung cancer in the majority die of metastases. Treatment options include surgery, chemo- and radiotherapy, targeted therapy by tyrosine kinase inhibitors (TKIs), and immuno-oncologic treatment. Despite the success with these treatment options, cure of lung cancer is achieved in only a...
Autor principal: | Popper, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653118/ https://www.ncbi.nlm.nih.gov/pubmed/33209649 http://dx.doi.org/10.21037/tlcr-20-175 |
Ejemplares similares
-
New developments in lung cancer diagnosis and pathological patient management strategies
por: Popper, Helmut
Publicado: (2020) -
Outsourcing predictive biomarker testing in non-small cell carcinoma: a personal view of pathologists
por: Brcic, Luka, et al.
Publicado: (2020) -
New insights into the interaction of the immune system with non-small cell lung carcinomas
por: Hofman, Paul
Publicado: (2020) -
A narrative review of digital pathology and artificial intelligence: focusing on lung cancer
por: Sakamoto, Taro, et al.
Publicado: (2020) -
Patient-derived cell line, xenograft and organoid models in lung cancer therapy
por: Huo, Ku-Geng, et al.
Publicado: (2020)